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Abstract
Background: As one of the most important components of harm reduction strategy for high-risk groups, following 
the HIV epidemics, Methadone Maintenance Treatment (MMT) has been initiated in prisoners since 2003. In this 
paper, we aimed to assess the advantages and shortcomings of the MMT program from the perspective of people 
who were involved with the delivery of prison healthcare in Iran.
Methods: On the basis of grounded theory and through conducting 14 Focus Group Discussions (FGDs), 7 FGDs 
among physicians, consultants, experts, and 7 FGDs among directors and managers of prisons (n= 140) have been 
performed. The respondents were asked about positive and negative elements of the MMT program in Iranian 
prisons. 
Results: This study included a total of 48 themes, of which 22 themes were related to advantages and the other 26 
were about shortcomings of MMT programs in the prisons. According to participants’ views “reduction of illegal 
drug use and high-risk injection”, “reduction of potentially high-risk behaviors” and “making positive attitudes” 
were the main advantages of MMT in prisons, while issues such as “inaccurate implementation”, “lack of skilled 
manpower” and “poor care after release from prison” were among the main shortcomings of MMT program.
Conclusions: MMT program in Iran’s prisons has achieved remarkable success in the field of harm reduction, 
but to obtain much more significant results, its shortcomings and weaknesses must be also taken into account by 
policy-makers. 
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Implications for policy makers
• Because of the mentioned positive feedback from the prisons’ staff , it is recommended that prisons continue the implementation of Methadone 
Maintenance Treatment (MMT) program. 
• It is found that healthcare providers and managers of the prisons agreed with the MMT program, but the main concerns go to the time after 
releasing from prison which was considered as one of the main drawbacks of this program form the participants’ view. 
• There is a need for skilled staff, using specific guidelines with certain objectives and exact implementation plans to achieve more success. 
Implications for public
Those people who were responsible for delivering of prison healthcare believed that Methadone Maintenance Treatment (MMT) programs, as a 
form of drug replacement therapy for opioid dependent individuals inside and outside prisoners, had remarkable benefits in reducing drug-related 
harms, risky behaviors and practices, lowering criminal behaviors, controlling HIV transmission and improving the lifestyle of the prisoners and 
their family. Thus, families’ support and continuity of care and treatment can improve the effectiveness of this program before and after release 
from prison. Therefore, despite all necessary educational programs for the patient/prisoners, all family members also need to be educated about the 
advantages of the program. 
Key Messages 
Background
Prisoners are considered as one of the high-risk groups who 
are prone to the acquisition and further transmission of 
HIV and other infectious diseases in many countries (1,2). 
Increased prevalence of HIV in prisoners, in comparison with 
general population, has been reported in the USA (ratio 6:1), 
and France (ratio 10:1) (3). In Iran, the prevalence of HIV has 
been reported as 1.28% (1) and 2.8% (4) in separate studies. 
Prisoners, especially those who inject drugs, are potentially 
at higher-risk of HIV infection (5–7). HIV outbreaks among 
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People Who Inject Drugs (PWIDs) in prisons have been 
reported in Iran (8) and other countries (9,10). Given the 
status of HIV epidemic among high-risk groups, especially 
prisoners, Iranian health authorities have tried to advocate for 
exhaustive control and prevention measures in- and out-side 
prisons. Since the early years of 2000s, policy-makers in Iran 
have established several harm reduction programs, among 
which Methadone Maintenance Treatment (MMT) has been 
one of the leading and important programs (11). 
Nowadays, MMT is used in different parts of the world to 
reduce harm among PWIDs inside and outside prisons. MMT 
is one of the most important measures of harm reduction 
programs, and has led to effectively reduction or termination 
of drug injection and shared practices (12–14) and also high-
risk sexual behaviors (12,15–19). This medication improves 
mental and physical conditions of patients and reduces the 
risk of diseases such as HIV/AIDS and hepatitis (20,21). 
According to studies, this method of treatment decreased 
mortality resulted from overdose, prevented withdrawal 
syndrome (22,23) and re-incarceration (24,25), and inhibited 
crimes initiated by illegal drug abuse; as a result, it provided 
infected people with the chance to improve their social health 
and life and involve in productive activities (26–30). 
Since early 2000s, multiple harm reduction programs 
including Needle and Syringe Exchange Program (NSEP), 
MMT, referral system to Voluntary Counseling and Testing 
centers (VCTs), psychological and mental counseling, and 
some other services like condom distribution have been 
designed to reduce HIV transmission from high-risk groups 
like PWIDs and prisoners to their partners and other 
potentially at risk individuals both within and outside prison 
(11,31). Throughout the Middle East and North Africa 
(MENA) region, harm reduction programs in Iran have been 
regarded as paradigms of best practices with remarkable 
impact in decelerating the propagation of HIV infection 
among PWIDs in- and out-side prisons (32). By the end 
of 2012, under the terms of Needle and Syringes exchange 
Program (NSP), more than 550 service centers had been 
distributing free needle and syringes among high-risk people 
in the community. However, based on the bio-behavioral 
surveys in Iran prisons in 2009 and 2013, inmates self-
reportedly acknowledged unsafe and shared injection in- and 
out-side prison. Given the implementation of harm reduction 
programs in Iran, MMT’s coverage among those who used or 
injected drugs grew up steadily from 2001 through the end of 
2012, so that around half a million drug users had received 
free MMT services (in- and out-side prisons) through more 
than 4,000 centers (33); however, injecting drug use is still 
the main mode of HIV transmission in Iran (accounted for 
more than 60% of new HIV infections), which accentuates the 
need for higher levels and consistence application of MMT 
coverage. 
However, because of the sensitivity of working on prisons 
in Iran, there is not much information available about the 
advantages and shortcomings of MMT in Iran. In a small 
scale study, Zamani et al. (34) carried out a research in only 
one prison in 2010 to determine the obstacles against the 
extension of MMT program from the viewpoints of prisoners 
which were lack of manpower and healthcare providers, 
methadone diversion, the potential adverse effects of the 
drug, and the stigma surrounding treatment by methadone. 
Recent studies in Iran have shown that activities of MMT 
centers have been cost-effective in HIV prevention and 
have averted about 128 new cases of HIV during only one 
year in 7 MMT sites (35) and also prevented HCV infection 
(36). Researchers in Malaysia recommended that prison-
based MMT program could be effectively implemented 
by improving a cogent link between prison and police 
authorities, preventing police harassment against MMT 
clients after their release, and improving systems for tracking 
release dates (28). Nowadays, there is now evidence-based 
information concerning the healthcare providers and 
mangers’ opinion who are directly involved in the MMT 
program, although it has been proved that implementation of 
MMT along with other harm reduction strategies in recent 
years have considerably helped in reducing new HIV cases 
(4,13). Having the feedback and opinions of  those individuals 
who worked on and provided this program can be useful 
for health policy-makers in this context. Although MMT 
program has been widely used in prisons in Iran, to the best 
of our knowledge no study has been conducted yet to assess 
qualitatively the outcomes of integrating and running the 
program in prisons from the side of the program providers in 
Iran. Thus, in this qualitative study, we visited key people who 
were dealing with the implementation of MMT and we asked 
their perspective about MMT program in Iran’s prisons. The 
aim of this study was to obtain the viewpoints of practitioners, 
consultants, experts, directors, and managers of prisons about 
the advantages and shortcomings of MMT programs in 
Iran’s prisons. 
Methods
Design and samples 
This qualitative study was carried out in Iran’s prisons. 
The main MMT providers including prison directors and 
managers, physicians and nurses, and consultants and 
psychologists of the prisons were enrolled in the study. The 
participants were recruited via purposive sampling with a 
heterogeneous approach. Those who had a history of less 
than six months of working with addicts, PWIDs, and people 
in need of MMT were excluded from the study. The people, 
participating in both types of Focus Group Discussions 
(FGDs), were from different prisons all around Iran. The 
researchers tried to select informant people in all prisons in 
Iran to participate in FGDs. 
Data collection
Data were collected using FGDs. Since the participants 
were not in the same positions, we made the discussions 
separately for two different groups to form homogeneous 
group discussions (37). Thus, 14 separate FGDs (with 7 to 
11 participants each) had been held, of which seven FGDs 
were carried out among prisons’ directors and managers and 
seven FGDs were done among physicians, consultants and 
psychologists involved in the MMT program and worked at 
the triangular sites of the prisons participants were guided 
via an open discussion by a skilled facilitator/moderator. The 
moderator attempted to use the idea of all participants during 
the discussions was made confident every participated, asked 
for details if necessary and tried to make strong interactions 
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among the subjects to reach to maximum and different 
opinions. These FGDs continued until the researchers found 
no fresh idea for each section. When the researchers realized 
that the discussions were not productive anymore, they 
decided to terminate or change the direction of the sessions 
to absorb the highest ideas. All FGDs were done at the health 
departments of the prisons. During FGDs, all the contents of 
participants’ discussion were audio recorded and latter, after 
the discussion, their main ideas were copied in hand written 
notes. Participants were free to leave the study anytime 
they wished. 
Data analysis and validity 
The handwritten and audio recorded texts were analyzed 
via content analysis and thematic framework methods (38). 
On the basis of researchers’ interpretation and deduction, 
after themes were extracted and encoded, similar codes were 
classified, integrated, and combined and the final results were 
extracted in accordance with the study objectives. 
Results
Findings of this study included a total of 48 codes, some 
of which were related to advantages and some others to 
shortcomings of MMT program in prisons. Most participants 
in the study said that MMT program was very positive in 
prisons and they put emphasis on its constructive effects on 
harm reduction in prisons. They believed that despite some 
problems and weaknesses, MMT had been successful and had 
a good result on prisons and even on community. Generally, 
after coding contents and combining similar codes, the results 
were categorized as strengths and weaknesses which are listed 
separately below:
A) Participants’ views about the efficacy of Methadone 
Maintenance Treatment (MMT) programs in prison 
(strengths)
Reduced shared injections
One of the most striking points concerning the MMT 
program in the view of the participants was its effects on 
reducing shared injections and subsequent reduction in the 
incidence of diseases which are transmitted through blood 
such as HIV and hepatitis.
Reduced drug abuse in prison
Participants said that the MMT program not only reduced the 
entry of drugs into the prison, but also decreased the need for, 
demand for, consumption, and trade of drugs and cigarettes.
Reduced crime
Participants believed that the MMT program could keep 
addicts calm in prison and could decrease crime; one of them 
said: “There has been an obvious reduction in escape, riot, 
tension, conflict and self-injury among the prisoners, especially 
addicts after the introduction of the MMT”.
Reduced consumption of drugs
Officials and participants believed that MMT increased 
addicts’ desire to quit drugs in prisons. They stated that: 
“After addicts are released from prison, they search for 
addiction treatment centers and counselors to continue 
their MMT programs”.
Reduced consumption of different types of drugs
One of the officials said that: “Prior to the implementation of 
MMT in prisons, ecstasy pills were highly consumed even in 
front of prison officials. However, after the initiation of MMT, 
consumption of these pills decreased significantly”.
Positive economic, social, and behavioral effects
Methadone brings addicts back to life. MMT program 
improves addicts’ personal and social lives and brings them 
back to the community; it also creates a sense of responsibility 
and responsiveness in addicts who are under the treatment. 
This treatment also develops a positive attitude among family 
members and community toward addicts.
Increased efficiency of training 
Participants believed that MMT made training and 
consulting programs more effective for addicts. One of the 
participants said: “Because of consumption of methadone, there 
is an increased level of enthusiasm to participate in sports and 
educational classes”.
Table 1 presents some of the other most important advantages 
of MMT which were declared by doctors, consultants, experts, 
directors and managers of the prisons.
B) Participants’ views about shortcomings of Methadone 
Maintenance Treatment (MMT) programs in prison 
(weakness)
Results of this study showed that although participants 
did not have a clear and strong disagreement with the 
implementation of this program, most of them believed that 
the program had not been implemented fully and was not in 
line with the designed protocols. After combining the codes, 
weaknesses and problems of this program were as follows 
(from participants’ viewpoints): 
Lack of sufficient manpower
Participants believed that the program was implemented 
incompletely due to shortage of staff; they also said that those 
who were working in prison were indeed the employees of 
other organizations. Accordingly, working in prison was not 
their first and main job. Thus, there was an unbalance between 
the number of employees and the number of prisoners who 
were under the coverage of the program.
Inaccurate implementation of the protocol
The program was not implemented along the lines of the 
protocol. In many cases, even the prison protocol was not 
fully implemented. “If this protocol is going to be implemented 
partially, we will obtain no positive feedback on its outcomes. 
Lack of proper, efficient and effective managerial strategies, 
especially in prisons is the main cause of the problem”. 
Using methadone only as a relaxing tool in prison
As one of the problems of the program, some of the normal 
and non-addicted prisoners voluntarily enrolled in the 
program in order to take methadone to pass detention period 
without any anxiety. Also, some less-addicted people chose 
methadone due to the sedation found in methadone. Using 
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the same treatment for all prisoners and ignoring differences 
between them has led to an increase in drug abuse. Methadone 
has short-term harm reduction effects, but in a long run it 
has many complications. “We give methadone to prisoners to 
calm them; it causes no problem for us and prevents them from 
fighting. It calms them here. But, what happens when they go 
back to community? We did not do what we have to do”. 
Deficiencies after leaving prison
Another major point which more than half of the 
participants pointed out was the problem of post-prison care. 
They believed that care provided outside the prisons was very 
weak and there was no special center to support and protect 
prisoners after their release. Moreover, inmates start drug 
abuse again after leaving prison. “If a person who enters the 
prison has the necessary indications, we include him in the 
treatment. The treatment mostly remains incomplete when he 
leaves the prison. Since treatment is free in prison, the prisoner 
wants to find free centers out of the prison but unfortunately 
there is no such a center outside”. 
Low awareness of the staff towards the program
Participants reported that both drug-dependant users and 
staff  who provided services and executed the program are not 
much aware of the principal objectives of the MMT program. 
They also stated that staff are not experienced; and personnel 
are not fully familiar with the prison environment. 
Lack of proper criteria for inclusion of people in the program
The program is not implemented scientifically since all 
addicts and even non-addicts are included in the methadone 
program. “As another problem of methadone plan, at first the 
authorities commended, in keeping with the first protocol, to 
only include people who had high-risk behaviors like those who 
injected drugs and those who used heroine or crack. But then, 
they told us to include everyone who wanted to use methadone”.
Other shortcomings mentioned by physicians, consultants, 
experts, directors and managers of prisons are summarized 
in Table 2.
Discussion
In this study, we identified positive points of the MMT 
program such as reduced injection, reduced demand and 
subsequent reduction in the availability and abuse of drugs 
in prison, increased tendency to withdraw, decreased 
consumption of narcotics and sedatives, emergence of a 
positive attitude in families and community, increased 
efficiency of training and consulting classes, establishing 
long-term and continuous connections between addicts 
and treatment centers or counseling teams, reduced rate 
of crimes like prostitution in order to obtain drugs, and 
reduced addiction expenses. on the other side, participants 
presented challenges of this program including inaccurate 
implementation of the designed protocols, shortage of skilled 
manpower and service providers, weakness in post-release 
continuity of care, low awareness of groups and community 
about various aspects of the program, lack of proper and 
efficient criteria for including people in the program, 
neglecting psychological problems of addicts, wrong policies 
Table 1. Viewpoints of physicians, consultants, experts, directors and managers on the advantages (strengths) of methadone therapy
Advantages (strengths) Further explanation plus participants’ original comments
A) views of physicians, consultants, and health and treatment experts in prisons
Improving the results in prisons during the 
implementation of the program
“Since the target group is a high-risk group who is hard to work with, little success of the program is 
valuable and the quality of program must improve in line with the development of services.  However, 
obvious changes are observed due to this program”.
Establishing a long-term and continuous 
connection between addicts and a drug  
treatment center in prison
“Methadone treatment motivates people to visit medical centers and personnel every day and receive 
more health and treatment services”. 
Changing the method of drug abuse from injecting 
drugs to taking drugs and reducing drug poisoning
“Methadone changes the method of drug abuse from injecting drugs to taking them and thus reduces 
injection and its problems and diseases in prisons and the community; it also reduces drug poisoning 
because its side effects is less than other  opiates”.
Reducing prostitution in order to provide drug “Since the majority of women who take methadone are sex workers and since we monitor some of them 
after they are released from prison, we see that these changes are made solely as a result of methadone 
program. That is, they don’t enter high-risk places and don’t have high-risk behaviors to get drugs”.
Reducing drug costs “Methadone cost is less than that of other drugs”.
Reducing addicts’ return to prison “Methadone reduces crime because it decreases people’s need for drug and thus reduces crime and 
return to prison”.
Reducing side effects of illegal drugs “Distributing methadone is useful by itself because it is pure and has no hazardous materials”.
B) Views of directors and managers of prisons
Presence of physician, psychologist and counselor 
in prisons
“Honestly, it is very effective when a doctor or psychologist speaks.  In the past, if a person had hepatitis 
or AIDS, he didn’t  have sex with his wife but now he has”. 
Preventing people from accusing  prison staff of 
bringing drugs to prisons
“It was said in the past that prison officers and personnel brought drugs to the prisons. MMT program 
exonerated them all”.
Reducing drug discovery in prison “MMT decreases drugs in prisons and thus fewer drugs will be found in prisons. Methadone has motivated 
prisoners to be unwilling to provide drugs from outside so less drugs will be discovered”.
Positive results of the treatment program after 
leaving prison
“Methadone  users who do not inject drugs anymore could interact with the social environment outside 
prison better and in some cases they may find a good and permanent job after they leave prison”.
MMT= Methadone Maintenance Treatment.
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in increasing the coverage of methadone therapy, slow 
implementation, and shortage of valid evaluation criteria.
There is growing scientific evidence that indicates 
commencing MMT before releasing from prison declines 
recurrent post-release substance use. McKenzie et al. 
(39) said that despite notable provider-related barriers 
to implement MMT for drug users in related centers and 
correctional settings, it is necessary to provide effective 
intervention methods via supplying methadone before 
releasing the prisoners. Nonetheless, one of the important and 
controversial points about MMT programs in Iran prisons 
is that other organizations do not support this program at 
social level and do not provide services for released prisoners. 
Clearly, some cities still lack methadone centers or centers for 
post-prison care; furthermore, other governmental centers do 
not accept addicts who are released from prisons. Moreover, 
since these people are poor, they are not able to find a job 
so they are likely to get addicted again after they are released 
from prison. It can be concluded that harm reduction and 
addiction treatment would become incomplete without 
the cooperation of other organizations outside the prison. 
A study, carried out in Belgium by De Maeyer et al. (15), 
emphasized the role of social and environmental support for 
addicts treated with methadone in order to increase quality of 
their lives. Another study conducted in Yunnan province of 
China indicated that some factors can influence the success 
of the program, including increased awareness of community 
and drug users about methadone, behavior therapy along 
with counseling, vocational training, increased interaction 
with the police and judicial authorities and the relationship 
with public health system (40).
Generally speaking, the objectives of methadone therapy in 
prisons are still not clear and obviously MMT is introduced 
as a way to reduce harm; if therapeutic effects is the main 
objective, some cases must be taken into consideration 
including presenting protocols with certain objectives 
and implementing the programs exactly. In other words, 
to understand methadone therapy completely, common 
objectives of withdrawal programs must be also taken into 
account: 1) Eliminating or reducing withdrawal symptoms, 2) 
Eliminating or reducing the craving for drugs, 3) Preventing 
recurrence of addiction, 4) Restoring the physiological activity 
level which has been lost due to drug abuse, and 5) Reducing 
criminal behaviors and improving behaviors that affect social 
Table 2. Viewpoints of physicians, consultants, experts, directors and managers on the weaknesses of the program
Shortcomings (weaknesses) Further explanation plus participants’ original comments
A) Views of physicians, consultants, and health and treatment experts of prisons
Expecting therapeutic effects out of methadone 
therapy program
“Objectives are unknown for inmates and officials; there are great expectations about the therapeutic 
effects of methadone treatment programs, while these expectations are not among the main objectives”.
Neglecting mental  problems and weakness in 
terms of psychological issues 
“People’s mental health is neglected; psychological services, primary assessment, referral, psychiatric 
services and medication are not provided appropriately”.
Buying and selling methadone in prison “In some cases, prisoner pours methadone into his mouth and doesn’t take it but rather sells it to another 
person. The second person also pours methadone in a glass and sells it to another one”.
Interferences  of some prison officials in 
the implementation process and lack of full 
cooperation
"Interference of some (albeit few) officials and non-specialized staff in giving methadone to inmates 
creates some problems for the physician and the medical team”.
Wrong policies to extend the coverage of the 
program 
“Authorities’ emphasis on increasing the quantity or number of covered people is a weak point; that is, 
the  number of people covered by the program is more important for them than the outcome”.
Not continuing the program and the tendency to 
stop the methadone in some addicts
“Due to the lack of euphoria and pleasure compared with those raised by other opioids, there is an 
excessive use of other drugs besides methadone therapy”.
Causing some problems such as homosexuality “Methadone, to some extent, brings addicts’ sexual desire back and in some cases it will cause problems 
like homosexuality in prison”.
Inappropriate methadone therapy by private 
section outside the prison 
“They perform methadone therapy in prison and they sell methadone out of prison and these two are 
contradictory. In prison, methadone comes with psychology and counseling but it is not the case outside. 
Thus, it affects methadone therapy in prisons, especially in prisons where a huge number of prisoners 
enter and exit”.
B) Views of directors and managers of prisons
Lack of proper and valid indicators to assess the 
progress and success of the program
“Now, there's no appropriate measure to evaluate the progress of the program clearly and definitely”.
Shortage of  space and facilities necessary 
to implement the program completely and 
appropriately
"Shortage of budget, staff, equipment and facilities of centers. These deficiencies sometimes cause the 
programs to be stopped".
Entering the program due to financial problems  
(prisoners’ poverty )
“In some cases, people select methadone because of poverty, not because of withdrawal".
Unfamiliarity of judges with the program "The judiciary does not completely agree with implementing such programs because judges are not 
aware of them and this causes problems in the programs”.
Stopping methadone as a punishment In some prisons, officials make the policy of stopping methadone as a punishment. They say: “Don’t give 
them the methadone”.
Paying more attention to big prisons and having 
problems in implementing the program in small 
prisons
“The focus on improving the program can be only seen in big prisons. In smaller prisons, however, 
methadone programs are not implemented as properly as the big ones; its implementation in small 
prisons is hard because of the shortage of facilities”.
Making threats by prisoners to receive 
methadone
“Prisoners threaten personnel to receive drugs and methadone and even commit intentional crimes to 
receive methadone. Sometimes, prisoners, themselves, select dose of methadone.”
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and psychological health (27,41–43).
Iran is considered as one of the most successful countries in 
the field of methadone therapy as a method of harm reduction 
(44), however, various studies conducted in other countries 
have also shown the success of methadone therapy in harm 
reduction, especially in reducing high-risk behaviors such 
as shared injection (15,19,28,41,45,46). Thus, according to 
the results of the present research, the weaknesses extracted 
from these programs can be a guide to review and continue 
MMT programs in Iran prisons. When its weaknesses are 
removed via scientific methods and its different aspects are 
supported by other non-governmental and governmental 
organizations, MMT can potentially reduce harm and lead 
to good therapeutic effects. There should be a strategic plan 
for this program in prisons. Such a plan should define clear 
standards for exclusion and inclusion of eligible individuals. 
The program should also undergo continuous monitoring 
and evaluation. 
There are some limitations for the current study. One of 
the main drawbacks of this study is that authors would like 
to ask the perspectives of the receivers of MMT programs, 
although other studies like Zamani et al. (34) explored the 
main positive and negative points of the MMT program 
from the prisoners’ view. Another one is that this study was 
a qualitative approach to explore the weakness and strength 
of MMT program; however, qualitative studies do not have 
rigorous power to show the main factors or elements of a 
program such as MMT; therefore, there is a need to make 
these qualitative themes to quantitative factors and explore 
the main positive and negative factors in figures and statistics. 
Conclusion
According to the findings of this research, it can be concluded 
that MMT programs have had considerable success not 
only in reducing drug-related harms, but also in improving 
prisoners’ lifestyle. However, to achieve more success it is 
necessary to recruit skilled manpower in all prisons, provide 
specific guidelines with certain objectives, implement the 
guidelines properly, and mobilize various governmental and 
non-governmental organizations. Because of its potential 
effect on harm reduction activities, it can reduce the risky 
behaviors like shared injection and the use of different illegal 
drugs, and lead to shifts from injection to non-injection use of 
drugs. Moreover, it can prevent the transmission of infectious 
diseases like HIV among prisoners. Providing sustainable 
and long-term cares, even after release form the prisons, is 
another option which has to be considered by health and 
administrative authorities. 
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